Call for Abstract
Scientific Program
13th International Conference on Depression, Anxiety and Stress Management, will be organized around the theme ““Transforming Mental Health: Innovative Strategies for Depression, Anxiety, Stress Management and Resilience””
Stress 2027 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Stress 2027
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
Explore advances in transcranial magnetic stimulation, electrical stimulation, neuromodulation, and related technologies for mental health treatment. Sessions will address neuroplasticity, treatment-resistant depression, anxiety interventions, personalized stimulation protocols, therapeutic mechanisms, safety, efficacy, patient selection, and future applications of non-invasive brain stimulation.
Explore global mental health challenges involving stigma, cultural influences, healthcare inequalities, accessibility, mental health literacy, community-based interventions, culturally adapted therapies, workforce shortages, scalable services, policy development, prevention, and equitable care. Sessions will examine innovative approaches for delivering effective mental health support across diverse populations and resource settings.
Examine depression, anxiety, loneliness, social isolation, cognitive changes, aging-related stress, resilience, healthy aging, community support, digital connectivity, psychological interventions, prevention, and comprehensive mental healthcare. Discussions will address strategies for protecting emotional well-being and promoting meaningful social engagement throughout later life and across generations.
Explore virtual reality, immersive environments, digital psychotherapy, exposure therapy, relaxation technologies, anxiety treatment, stress reduction, behavioral training, therapeutic simulations, patient engagement, accessibility, safety, and clinical effectiveness. Sessions will highlight emerging opportunities for using immersive technologies to complement traditional psychological interventions and expand mental healthcare access.
Investigate emerging pharmacological approaches for depression and anxiety, including novel mechanisms, rapid-acting therapies, combination treatments, pharmacogenomics, treatment-resistant depression, new drug targets, personalized pharmacotherapy, clinical trials, safety, efficacy, and future therapeutic strategies designed to improve response among individuals who do not benefit from conventional treatments.
Explore innovative approaches to suicide prevention, including risk assessment, early identification, predictive models, crisis intervention, protective factors, digital prevention tools, community programs, clinical safety, resilience, postvention, and multidisciplinary care. Discussions will focus on evidence-based strategies for reducing suicide risk and strengthening mental health support systems.
Examine the interaction between depression, anxiety, stress, and chronic diseases such as cardiovascular disorders, diabetes, cancer, chronic pain, and neurological conditions. Sessions will address treatment adherence, psychological interventions, integrated care models, patient resilience, collaborative healthcare, and strategies for improving both mental and physical health outcomes.
Explore emerging evidence connecting nutrition, metabolism, gut health, and psychological well-being. Topics include dietary patterns, micronutrients, metabolic pathways, inflammation, microbiota, nutritional deficiencies, mood regulation, depression, anxiety, lifestyle medicine, dietary interventions, personalized nutrition, and the potential role of nutritional psychiatry in comprehensive mental healthcare.
Investigate the complex relationship between sleep and psychological health, focusing on insomnia, circadian disruption, depression, anxiety, stress, sleep biomarkers, physiological mechanisms, behavioral sleep interventions, chronotherapy, digital monitoring, lifestyle modification, and integrated strategies for improving sleep quality and supporting long-term mental wellness.
Examine workplace stress, burnout, technostress, psychological safety, employee depression and anxiety, workload, work-life balance, leadership, organizational culture, remote and hybrid work challenges, employee assistance programs, workplace interventions, and resilience strategies designed to create healthier, more productive, and psychologically supportive professional environments.
Explore the psychological and biological consequences of trauma, including PTSD, complex trauma, childhood adversity, emotional dysregulation, and chronic stress. Sessions will examine trauma-informed care, evidence-based therapies, resilience, post-traumatic growth, psychological recovery, crisis intervention, prevention, and long-term strategies for supporting trauma survivors.
Investigate relationships between social media use, digital addiction, social comparison, cyberbullying, loneliness, sleep disruption, depression, anxiety, and emotional well-being. Discussions will explore behavioral mechanisms, risk factors, healthy technology use, digital wellness interventions, prevention strategies, online support networks, and responsible digital engagement.
Address emerging mental health challenges among children, adolescents, and young adults, including depression, anxiety, academic stress, social media exposure, cyberbullying, emotional regulation, family dynamics, early intervention, school-based programs, digital therapies, resilience development, prevention, and age-appropriate strategies for promoting psychological well-being.
Explore emerging research on depression, including neurobiological mechanisms, biomarkers, treatment-resistant depression, early diagnosis, precision psychiatry, pharmacological innovations, psychotherapy, digital interventions, relapse prevention, and personalized treatment strategies designed to improve clinical outcomes and enhance long-term recovery and psychological well-being.
Investigate the neural mechanisms underlying depression, anxiety, and stress through neuroimaging and cognitive neuroscience. Topics include functional connectivity, neural circuitry, emotional processing, cognitive dysfunction, neuroplasticity, stress-related brain changes, brain biomarkers, and emerging neuroscience-based approaches for improving psychiatric diagnosis and therapeutic development.
Explore individualized approaches to psychiatric care using biomarkers, pharmacogenomics, patient stratification, predictive models, treatment-response indicators, personalized psychotherapy, digital health data, and clinical decision-support systems. Sessions will examine how precision psychiatry can improve diagnosis, treatment selection, therapeutic response, patient engagement, and long-term outcomes.
Examine innovative developments in psychotherapy, including cognitive behavioral therapy, acceptance and commitment therapy, dialectical behavior therapy, behavioral activation, interpersonal psychotherapy, trauma-focused approaches, integrative therapies, personalized treatment, digital delivery, therapist-assisted interventions, treatment effectiveness, accessibility, and long-term outcomes across diverse patient populations.
Investigate psychological resilience and emotional regulation as protective factors against depression, anxiety, and stress. Sessions will explore self-compassion, coping mechanisms, optimism, social connectedness, post-traumatic growth, positive psychology, resilience training, preventive interventions, and sustainable strategies for strengthening individual and community mental well-being.
Explore scientific evidence surrounding mindfulness, meditation, emotional regulation, stress reduction, neuroplasticity, attention, contemplative neuroscience, physiological responses, and psychological well-being. Discussions will examine mindfulness-based interventions, meditation practices, digital mindfulness programs, clinical applications, and innovative approaches for managing depression, anxiety, and stress.
Investigate the relationship between neuroinflammation, immune dysfunction, and mental health disorders. Sessions will examine cytokines, inflammatory biomarkers, oxidative stress, immune–brain interactions, depression, anxiety, chronic stress, potential therapeutic targets, and emerging anti-inflammatory approaches that could contribute to improved psychiatric diagnosis and treatment.
Explore emerging connections between the gut microbiome and psychological health, including microbiota diversity, gut–brain communication, psychobiotics, inflammation, nutrition, metabolic pathways, intestinal health, mood regulation, anxiety mechanisms, and personalized interventions. Researchers will discuss promising microbiome-based strategies for understanding and managing depression, anxiety, and stress.
Examine how smartphones, wearable devices, behavioral data, and digital biomarkers can support early detection and prediction of depression, anxiety, and stress. Discussions will address continuous monitoring, predictive analytics, personalized risk assessment, remote healthcare, data interpretation, privacy, and clinically meaningful digital mental health applications.
Explore artificial intelligence, machine learning, generative AI, digital therapeutics, telepsychiatry, AI-assisted assessment, virtual psychological support, predictive analytics, personalized interventions, and clinical decision-making. Sessions will also examine ethical challenges, privacy, safety, accessibility, responsible AI development, and opportunities for transforming mental health services.
Investigate the complex effects of chronic stress on the brain and body, including HPA-axis dysfunction, inflammation, neuroplasticity, cognitive changes, sleep disruption, physiological responses, behavioral consequences, workplace stress, resilience mechanisms, and innovative prevention and intervention strategies for sustainable psychological and physical well-being.
Examine advances in anxiety research covering generalized anxiety, panic disorder, social anxiety, phobias, cognitive mechanisms, neurobiology, exposure-based therapies, pharmacological interventions, digital treatments, early detection, personalized care, and innovative therapeutic approaches aimed at reducing symptoms and improving quality of life.
